“Clinical trials create valuable new evidence that is so urgently required in complementary and integrative medicine.”

Dr Janet Schloss

Clinical Research Fellow and Lecturer

Clinical Trials at the National Centre for Naturopathic Medicine

The National Centre for Naturopathic Medicine has a strong focus on strengthening traditional, complementary and integrative medicine approaches via rigorous research, including through our clinical trials program.  

Naturopathic medicine offers potential solutions for addressing major health care problems of the future. Conducting clinical trials in the area of non-pharmacological interventions will potentially benefit trial participants, while in the longer term aims to benefit the community and relieve the strain on the health care system. 

If you are interested in one of our current trials, please use the links below to access more information about the studies, and apply:
 

 
Close up shot of cannabis in field

Do you suffer from poor sleep?

Southern Cross University researchers are investigating the efficacy of an over-the-counter botanical cannabidiol (CBD) product to help with sleep disturbances in women and men.

They are seeking generally healthy individuals aged 18-65 years old, who have self-reported poor sleep. This may include people who have difficulty initiating sleep, maintaining sleep, or are waking earlier than desired. Participants can partake in the trial in Melbourne, Sydney, Brisbane or Lismore. Each participant will partake in the trial for 10 weeks.

This trial involves participation in a randomized placebo-controlled clinical trial, which means participants will receive either a placebo or an active product. A placebo is a treatment which is designed to have no therapeutic value, but is similar in look, taste and smell to the other treatment being tested.

This clinical trial has approval from the Southern Cross University Human Research Ethics Committee, SCU HREC number: 2021/031

For more information about the clinical trial or to check if you are eligible to participate, please visit the below website. The patient information sheet can be obtained by contacting the lead researcher, Dr Janet Schloss.

Email ncnmtrials@scu.edu.au,
or call 0436 101 306 or 02 6626 9255

Check your eligibility here   

 
Person standing on scales

Are you concerned about your weight?

Southern Cross University researchers are investigating the efficacy of a herbal product for weight loss in men and women in Australia.

They are seeking generally healthy adults aged between 18 and 60 years who are considered to be overweight to take a herbal weight loss product or placebo for 16 weeks (4 months).

Overweight is considered to be anyone who has a body mass index (BMI) between 25 to 29.9kg/m2. This study involves participation in a randomised placebo-controlled clinical trial.

This trial involves participation in a randomized controlled clinical trial, which means participants will receive either a placebo or an active product. A placebo is a treatment which is designed to have no therapeutic value, but is similar in look, taste and smell to the other treatment being tested. 

There will be three trial sites, at Southern Cross University’s Lismore and Gold Coast campuses, and at Body Organics in Brisbane. If you qualify, you would be required to come to the nominated trial site once a month for 16 weeks (4 months). 

This clinical trial has approval from the Southern Cross University Human Research Ethics Committee, SCU HREC number: 2021/033 

For more information about the clinical trial or to check if you are eligible to participate, please visit the below website. The patient information sheet can be obtained by contacting the lead researcher, Dr Janet Schloss. 

Email ncnmtrials@scu.edu.au,
or call 0436 101 306 or 02 6626 9255

Check your eligibility here   

 
Woman sitting on couch

Do you suffer from menopausal symptoms?

Southern Cross University researchers are conducting a clinical trial to assess the effectiveness of a herbal formula for women experiencing menopausal symptoms.

Changes in reproductive hormones during the menopausal transition can wreak havoc on womens lives, with symptoms such as daytime hot flashes, night sweats, sleep disturbances, weight gain, headaches and mood changes. This herbal formula is currently available on the market. Testimonials by some women have stated that it helped to reduce their menopausal symptoms.

It is an online telehealth trial, so is open to women from anywhere in Australia and you will not be required to visit a trial site. The trial is a herbal medicine based trial for 12 weeks. 

This clinical trial aims to assess the effectiveness of a herbal formula for women experiencing menopausal symptoms. Involvement will include participation in a phase II randomized placebo-controlled clinical trial, which means participants will be given either a placebo or an active product. A placebo is a treatment which is designed to have no therapeutic value, but is similar in look, taste and smell to the other treatment being tested. 

They are seeking generally healthy menopausal women aged between 40 and 66 years who experience 3 or more vasomotor symptoms (hot flushes) within a 24-hour period.

This clinical trial has approval from the Southern Cross University Human Research Ethics Committee, SCU HREC number: 2021/036 

For more information about the clinical trial or to check if you are eligible to participate, please visit the below website. The patient information sheet can be obtained by contacting the lead researcher, Dr Janet Schloss. 

(This trial is not currently recruiting new participants)

Check your eligibility here   

 
Spoon of Kefir held above jug of milk

Effects of Kefir on the Microbiome

Southern Cross University researchers are conducting a clinical trial, examining whether the consumption of Kefir can influence the microbiome.

Kefir is a probiotic dairy beverage that has been consumed for over 2,000 years in the Caucasus region at the border of Europe and Asia. Traditional Kefir is made by taking milk and adding Kefir ‘grains’ which contain a range of symbiotic bacteria and yeast species. Many claims have been made regarding the health benefits of Kefir, however little is known about the effects of Kefir on the microbiome, the collective bacteria in the mouth and gut.

The team are seeking healthy adults with a Body Mass Index between 18.5 and 30 kg/m2, who have no acute or chronic disease. Participants will be required to consume Kefir two times per day for two weeks. Those with gastrointestinal conditions such as Irritable Bowel Syndrome, Ulcerative Colitis or Crohn’s Disease, Celiac disease, lactose intolerance, or dairy allergy, plus those already using fermented foods for health purposes, will not able to participate.

At the beginning of the study, after two weeks of using Kefir, and after another two weeks without Kefir, participants will be asked to fill out questionnaires, and provide oral and stool samples. These samples will be analysed at the Microbiome Research Centre at the University of New South Wales in Sydney.

Due to COVID restrictions, the University is trialling a contactless study approach, whereby a collection site for the study products and samples will be set up at Southern Cross University’s Lismore campus. All other processes will be conducted remotely, via phone and online.

This clinical trial has been approved by the Southern Cross University Human Research Ethics Committee, #2021/129, and by the University of New South Wales Human Research Ethics Committee, #2021/RL00200.

For more information about the clinical trial or to check if you are eligible to participate, please contact the lead researcher, Associate Professor Romy Lauche PhD.

Email ncnmtrials@scu.edu.au,
or call 02 6626 9255

+